Deputy Minister of Organization Department of Suzhou Municipal Party Committee and Delegation Visits HymonBio

On the afternoon of February 2, Zhai Keqiang, Deputy Director of the Organization Department of the Suzhou Municipal Party Committee, and his delegation came to HymonBio to visit and investigate the enterprise construction, technology research and development, and how the company operates. Among them included: Ye Hao, Director of the Talent Division of the Organization Department of the Suzhou Municipal Party Committee; Shi Jing, Member of the Standing Committee of the Taicang Municipal Party Committee and Director of the Organization Department; Wang Weifeng, Executive Deputy Director of the Organization Department of the Municipal Party Committee; and Zhu Yongming, Member of the Party Working Committee and Deputy Director of the Management Committee of the Taicang Port Economic and Technological Development Zone.

Dr. Tammy Tan, CEO of HymonBio Co. Ltd., introduced the company to the group, from its development plan and core technology to domestic and foreign products and market layout. In order to meet demands, HymonBio uses three innovative core technologies: Molecular Lock Amplification Technology, Magnetic Bead Extraction Technology, and “One-Step” Method. At present, the company uses dual-pipeline layout focusing on infectious diseases and tumor early detection. Of 30 patent applications, they received 13 authorized patents, 11 products have obtained Chinese medical device certification, 9 received EU CE, and the Hymon® SARS-CoV-2 Test Kit received an US FDA EUA.

In the direction of cancer early detection, among them include test kits for screening colorectal cancer, lung cancer, and pan-tumor. The company’s colorectal cancer has been used in clinical trials since its research and development in 2017, with compliance rates of up to 90%. In the direction of emerging infectious diseases, it includes COVID-19, tuberculosis, AIDS, and others, of which 70% of SARS-CoV-2 Test Kits are sold to the United States.

Minister Zhai Keqiang greatly acknowledges HymonBio’s innovation and development. He said the current social economy is in a period of rapid development; maintaining technological innovation is not the sole core competitiveness for enterprises. They also need to be market-oriented and develop such products, and achieve leapfrog developments.